Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response

A low response rate limits the application of immune checkpoint inhibitors (ICIs) in the treatment of esophageal adenocarcinoma (EAC), which requires the precise characterization of heterogeneous tumor microenvironments. This study aimed to identify the molecular features and tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Chen, Zhou, Xiuman, Gao, Yanfeng, Sui, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144862/
https://www.ncbi.nlm.nih.gov/pubmed/35631431
http://dx.doi.org/10.3390/ph15050605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144862/
https://www.ncbi.nlm.nih.gov/pubmed/35631431
http://dx.doi.org/10.3390/ph15050605

Ejemplares similares